Aluminium Toxicity

What is in vaccines is not aluminium really. It is immensely more toxic and in nano particle form. It is called ALHS. Dr Suzanne Humphries has lectured about it. Janine Roberts has written about it.

https://youtu.be/mv_N5qByF-U

I want you to compare these two charts. One is the aluminum content found in the brain tissue of an Alzheimer’s patient, aluminum measured mcg/ g of tissue. The other is the amount of aluminum in childhood vaccines.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088403/

Healthy babies may be able to handle quantities of aluminum above FDA toxicity levels indicated for patients with impaired kidney function. However, no one knows how much more aluminum is safe because adequate studies were never conducted. In addition, babies are not screened for renal function prior to vaccination.

Therefore, it is impossible to know ahead of time which babies will succumb to aluminum poisoning.

Click to access miller.pdf

Hepatitis B – 250 mcg
DTaP – depending on the manufacturer, ranges from 170 to 625 mcg
Pneumococcus – 125 mcg
Hepatitis A – 250 mcg
HPV – 225 mcg
Pentacel (DTaP, HIB and Polio combo vaccine) – 330 mcg
Pediarix (DTaP, Hep B and Polio combo vaccine) – 850 mcg

http://www.vaccinationcouncil.org/2009/06/10/aluminum-and-vaccine-ingredients-what-do-we-know-what-don%E2%80%99t-we-know/

Aluminum was found in concentrations deemed to be pathologically-significant in each of the four main lobes and pathologically-concerning in the hippocampus. Aluminum content was especially high in occipital and parietal lobes and was coincident with significant Alzheimer’s disease-related neuropathology.”

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088403/…

“Aluminium is neurotoxic [11] and [23] and the concentrations of aluminium found in these familial AD brains are unlikely to be benign and indeed are highly likely to have contributed to both the onset and the aggressive nature of any ongoing AD in these individuals. These data lend support to the recent conclusion that brain aluminium will contribute towards all forms of AD under certain conditions [15].”

The aluminium content of brain tissue donated by individuals with a diagnosis of familial and probable familial Alzheimer’s disease was, overall, extremely high. The mean aluminium data for each lobe across all 12 donors are significantly higher (P < 0.05 in each case) than equivalent data (using identical methods and quality assurance indices) for the same lobes from a previous study which included 60 human brains of which ca 60% had been diagnosed as sporadic Alzheimer’s disease [8] and [12]. Herein we measured some of the highest values recorded for individual samples of human brain tissue, for example to highlight just a few, 11.54 μg/g in the occipital lobe of donor A2, 13.41 μg/g in the frontal lobe of A5, 25.80 μg/g in the occipital lobe of A6, 35.65 μg/g in the frontal lobe of A8 and 23.93 μg/g in the occipital lobe of A11 (Table 1). T
http://www.sciencedirect.com/…/article/pii/S0946672X16303777

ALUMINUM – The neurotoxic properties of aluminium are well established…

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782734/

Aluminum is a heavy metal with known neurotoxic effects on human and animal nervous systems. http://www.vaccinationcouncil.org/…/aluminum-and…/

In healthy subjects, only 0.3% of orally administered aluminum is absorbed via the gastrointestinal (GI) tract, and the kidneys effectively eliminate aluminum from the human body. Only when the GI barrier is bypassed… does aluminum have the potential to accumulate. If a significant aluminum load exceeds the body’s excretory capacity, the excess is deposited in various tissues, including bone, brain, liver, heart, spleen, and muscle. This accumulation causes morbidity and mortality through various mechanisms. http://emedicine.medscape.com/article/165315-overview

The adverse effects of aluminium that have been reported in recent years include Alzheimer’s disease, dementia and hyperactivity and learning disorders in children. https://www.ncbi.nlm.nih.gov/pubmed/1795349

Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5mcg/kg/day (five pound baby = no more than 11mcg/day) accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration. https://www.accessdata.fda.gov/…/2004/19626scs019ltr.pdf